Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Correction to: SEOM clinical guideline for treatment of kidney cancer (2017).

Gallardo E, Méndez-Vidal MJ, Pérez-Gracia JL, Sepúlveda-Sánchez JM, Campayo M, Chirivella-González I, García-Del-Muro X, González-Del-Alba A, Grande E, Suárez C.

Clin Transl Oncol. 2019 May;21(5):692-693. doi: 10.1007/s12094-019-02058-2.

PMID:
30798511
2.

miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer.

Campayo M, Navarro A, Benítez JC, Santasusagna S, Ferrer C, Monzó M, Cirera L.

PLoS One. 2018 Nov 2;13(11):e0206542. doi: 10.1371/journal.pone.0206542. eCollection 2018.

3.

Malignant Pleural Mesothelioma: The Last 8 Years of Experience in Our Area.

Benítez JC, Campayo M, Call S, Bastús R.

Arch Bronconeumol. 2018 Dec;54(12):637-638. doi: 10.1016/j.arbres.2018.03.012. Epub 2018 May 24. English, Spanish. No abstract available.

4.

Prognostic and Predictive Factors for Renal Cell Carcinoma.

Suárez C, Campayo M, Bastús R, Castillo S, Etxanitz O, Guix M, Sala N, Gallardo E.

Target Oncol. 2018 Jun;13(3):309-331. doi: 10.1007/s11523-018-0557-2. Review.

PMID:
29569164
5.

Leptomeningeal Carcinomatosis in a Patient With Clinical Stage III Lung Adenocarcinoma and Sudden Neurological Impairment.

Benítez JC, Bastús R, Luizaga L, Cirera L, Campayo M.

Arch Bronconeumol. 2018 Jun;54(6):344-345. doi: 10.1016/j.arbres.2018.01.019. Epub 2018 Feb 26. English, Spanish. No abstract available.

6.

SEOM clinical guideline for treatment of kidney cancer (2017).

Gallardo E, Méndez-Vidal MJ, Pérez-Gracia JL, Sepúlveda-Sánchez JM, Campayo M, Chirivella-González I, García-Del-Muro X, González-Del-Alba A, Grande E, Suárez C.

Clin Transl Oncol. 2018 Jan;20(1):47-56. doi: 10.1007/s12094-017-1765-4. Epub 2017 Nov 13. Erratum in: Clin Transl Oncol. 2019 May;21(5):692-693.

7.

miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma.

Tejero R, Navarro A, Campayo M, Viñolas N, Marrades RM, Cordeiro A, Ruíz-Martínez M, Santasusagna S, Molins L, Ramirez J, Monzó M.

PLoS One. 2014 Jul 8;9(7):e101899. doi: 10.1371/journal.pone.0101899. eCollection 2014.

8.

Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer.

Campayo M, Navarro A, Viñolas N, Diaz T, Tejero R, Gimferrer JM, Molins L, Cabanas ML, Ramirez J, Monzo M, Marrades R.

Eur Respir J. 2013 May;41(5):1172-8. doi: 10.1183/09031936.00048712. Epub 2012 Jul 26.

9.

A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.

Campayo M, Navarro A, Viñolas N, Tejero R, Muñoz C, Diaz T, Marrades R, Cabanas ML, Gimferrer JM, Gascon P, Ramirez J, Monzo M.

PLoS One. 2011;6(7):e22509. doi: 10.1371/journal.pone.0022509. Epub 2011 Jul 25.

10.

Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.

Navarro A, Diaz T, Gallardo E, Viñolas N, Marrades RM, Gel B, Campayo M, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J, Monzo M.

J Surg Oncol. 2011 Apr;103(5):411-5. doi: 10.1002/jso.21847. Epub 2010 Dec 29.

PMID:
21400525
11.

Single nucleotide polymorphisms in tobacco metabolism and DNA repair genes and prognosis in resected non-small-cell lung cancer.

Campayo M, Viñolas N, Navarro A, Carcereny E, Casas F, Gel B, Diaz T, Gimferrer JM, Marrades RM, Ramirez J, Monzo M.

J Surg Res. 2011 May 1;167(1):e5-12. doi: 10.1016/j.jss.2011.01.007. Epub 2011 Feb 2.

PMID:
21324488
12.

Long-term results of a phase II trial of induction paclitaxel-carboplatin followed by concurrent radiation therapy and weekly paclitaxel and consolidation paclitaxel-carboplatin in stage III non-small cell lung cancer.

Casas F, Viñolas N, Ferrer F, Agustí C, Sanchez M, Maria Gimferrer J, Lomeña F, Campayo M, Jeremic B.

J Thorac Oncol. 2011 Jan;6(1):79-85. doi: 10.1097/JTO.0b013e318200e563.

13.

Gene single nucleotide polymorphism accumulation improves survival in advanced head and neck cancer patients treated with weekly paclitaxel.

Grau JJ, Caballero M, Campayo M, Jansa S, Vargas M, Alós L, Monzo M.

Laryngoscope. 2009 Aug;119(8):1484-90. doi: 10.1002/lary.20254.

PMID:
19504558
14.

Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy.

Grau JJ, Caballero M, Monzó M, Muñoz-García C, Domingo-Domenech J, Navarro A, Conill C, Campayo M, Bombí JA.

J Surg Oncol. 2008 Aug 1;98(2):130-4. doi: 10.1002/jso.21096.

PMID:
18537153

Supplemental Content

Loading ...
Support Center